Editorial 2: Why the immune system doesn’t attack the body
Context:
The 2025 Nobel Prize in Physiology or Medicine has been awarded to three scientists- Marve E. Tregan from the National Institutes of Health (US), Frederick L. Semmler from the University of Cambridge, and Shimon Takeda from Duke University (Japan/US) - for their pioneering discovery of how a special type of immune cell prevents the body’s defense system from turning against itself.
Role of immune system in human body:
- The immune system’s primary job is to defend the body from harmful invaders such as bacteria, viruses, and other pathogens.
- It does this through white blood cells called T cells, which recognize and destroy infected or foreign cells.
- However, this same system poses a risk: if T cells were to mistakenly recognize the body’s own cells as foreign, they would trigger autoimmune diseases like Type 1 diabetes, rheumatoid arthritis, or lupus.
- For decades, scientists have wondered how the body prevents this internal self-destruction — how the immune system “knows” not to attack itself.
- The 2025 Nobel laureates’ discovery provides the missing link: a special type of T cells known as regulatory T cells (Tregs) act as the immune system’s “police,” keeping potentially harmful immune reactions in check.
The Discovery:
- Marve Tregan’s early experiments in the late 1990s hinted that a subset of T cells had a suppressive effect on immune activity.
- However, their exact identity and mechanism were not clear. Building on her work, Frederick Semmler developed genetically engineered mouse models in the early 2000s to observe how certain T cells behaved when exposed to self-antigens.
- His experiments showed that removing this special subset led to uncontrolled inflammation and tissue damage — clear evidence that these cells were crucial in preventing self-attack.
- Shimon Takeda’s contribution came through molecular biology. He identified a key transcription factor, FOXP3, which acts as the “master switch” for the development and function of these regulatory T cells.
- Mutations in the FOXP3 gene were later found to cause severe autoimmune conditions in humans, further confirming the importance of Tregs in maintaining immune tolerance.
Working mechanism of Regulatory T cells:
- The Nobel-winning trio revealed that regulatory T cells perform a complex set of tasks to prevent autoimmunity.
- They secrete inhibitory molecules like IL-10 and TGF-beta, which dampen excessive immune responses.
- They also interact directly with other immune cells — especially helper T cells and antigen-presenting cells — to suppress their activation.
- In simpler terms, while “effector” T cells act as the army that attacks invaders, Tregs act as the police, ensuring that the army does not mistakenly attack civilians (the body’s own tissues).
- The presence of these cells creates a delicate balance — a constant negotiation between aggression and restraint within the immune system.
Significance of the Research:
- This discovery has far-reaching implications for medicine.
- By understanding how Tregs maintain immune tolerance, scientists can explore new treatments for both autoimmune diseases (where the immune system is overactive) and cancers (where it is underactive).
- Autoimmune therapies could focus on boosting the function or numbers of Tregs to control diseases like multiple sclerosis or Crohn’s disease.
- Cancer immunotherapy, on the other hand, may target Tregs to prevent them from suppressing the immune system’s attack on tumors.
- The understanding of FOXP3’s role has already influenced drug development and diagnostic tests.
- It provides a genetic and molecular explanation for disorders that were once poorly understood.
- Beyond clinical applications, this discovery reshapes how scientists think about the immune system.
- It challenges the traditional “attack vs. defend” model and highlights the importance of self-regulation and tolerance.
- The Nobel Committee emphasized that the trio’s work “illuminates one of biology’s deepest mysteries — how life protects itself from itself.”
- Their discoveries also bridge gaps between immunology, genetics, and even neuroscience, as researchers now explore how immune tolerance might influence inflammatory conditions in the brain.
- The award also highlights the collaborative nature of modern science.
- Although the laureates worked independently, their findings complemented each other — from animal models to human genetics to cellular mechanisms — creating a coherent understanding of immune regulation.
Way Forward:
The 2025 Nobel Prize in Physiology or Medicine celebrates a discovery that not only solves a long-standing biological mystery but also opens up new frontiers in treating disease. The identification of regulatory T cells and the FOXP3 gene explains why the immune system doesn’t attack the body — a fundamental safeguard of life itself. The discovery of mechanism of immune system’s self-control mechanism redefines our understanding of health, disease, and therapeutic possibilities, making it one of the most significant breakthroughs in modern immunology.